TKNO — Alpha Teknova Inc

Alpha Teknova Inc (TKNO) is a drug manufacturers - specialty & generic company listed on NASDAQ. It is led by Stephen Gunstream, based in 2451 Bert Dr., Hollister, CA, United States, 95023, with about 158 employees. Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Latest reported TKNO revenue for 2025-09-30 was $10.5M. Net income was -$4.3M. Revenue was up 1.6% from 2025-06-30 to 2025-09-30. TKNO currently screens at market cap $221.4M.

Use this TKNO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TKNO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TKNO SEC filings page. Lician reads the product cache first so this HTML stays unique to Alpha Teknova Inc even when a live quote feed is slow.